With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.

Studies show outperformance of founder-led companies for investors, including one from Credit Suisse and numerous listed on ...

First FDA-Cleared Antibiotic-Eluting BioEnvelope Now Available in U.S. for Implantable Pacemakers, Defibrillators, and NeurostimulatorsSILVER ...

Topical Gel pre-IND meeting and on track to begin Phase 2a clinical trial in alopecia areata in Q2 2025 Unaudited cash and cash equivalents of approximately $70 million as of December 31, 2024 WARREN, ...

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

As the community of Pacific Palisades in the city of Los Angeles burned to the ground Tuesday night, LA Mayor Karen Bass was ...

Graft-Versus-Host disease market Insights. DelveInsight's Graft-Versus-Host Disease Market report offers an in-depth understanding of the epidemiology and ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

Novavax (NVAX) witnessed a jump in share price last session on above-average ... NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress ...

Fine-grained white, sugary matrix with very fine-grained clusters of apatite along ... Snow Lake's ability to develop the ...

As we age, joint pain often becomes an unwelcome companion, limiting our mobility and affecting our quality of life. For many ...

The Price City Council faced a lengthy agenda during their inaugural meeting of 2025. The meeting began with a quarterly ...